This page shows the latest Acquisition news and features for those working in and with pharma, biotech and healthcare.
The company’s chief executive officer, Richard Saynor, said at the time that the acquisition would “significantly reinforce the Sandoz global hospital offering, as well as complement [its] existing global leadership ... Sandoz also successfully
Through the acquisition, Ipsen will gain access to Bylvay (odevixibat), a non-systemic ileal bile acid transport inhibitor which gained US and EU approval in 2021 for the treatment of paediatric ... Commenting on the acquisition, Ipsen’s chief
BioNTech said in a statement that the acquisition supported its strategy to ‘build capabilities in AI-driven drug discovery and development of next-generation immunotherapies and vaccines to address diseases with ... The acquisition builds on the
Through the acquisition, AZ will gain access to baxdrostat (CIN-107), CinCor’s experimental aldosterone synthase inhibitor currently in development to treat conditions such as chronic kidney disease (CKD) and ... CinCor’s chief executive officer,
Moderna has announced it will acquire Japan-based DNA supplier OriCiro Genomics K.K (OriCiro) for $85m, marking the US company’s first acquisition since its 2010 launch. ... Through the acquisition, Moderna will obtain OriCiro’s tools for cell-free
The acquisition will include Tmunity’s ‘armoured’ CAR T technology platform. Kite, a Gilead Company, has agreed to buy Tmunity Therapeutics (Tmunity), a private, clinical-stage biotech focused on cell therapy. ... As part of Kite’s acquisition,
More from news
Approximately 203 fully matching, plus 1,332 partially matching documents found.
This approach informs everything we do, from R&D through platform acquisitions to patient and physician relations.
HTA outcomes can have an impact on the negotiated acquisition price of drugs, and maximising the contribution of PROs is important.
There are now three businesses within the group, Bedrock Healthcare Communications, Origins Insights and our recent acquisition, Anthem PR.
Many organisations have reduced sales teams or are transforming them into more MSL-focused roles, and skills acquisition is being seen as a core investment.
In fact, with the recent acquisition of PRA Health Sciences, the importance of this area was highlighted as we launched our new values to the combined organisation, with ‘inclusion’ firmly embedded ... DAWN: the Disability Awareness Network.
More from intelligence
Approximately 75 fully matching, plus 101 partially matching documents found.
In February, Fishawack announced its acquisition of The Hive Health Group, a healthcare marketing and scientific communications agency with a presence in both the UK and US.
At Ashfield Advisory, she will be responsible for driving all aspects of the company’s strategy and will work closely with the mergers and acquisitions team, while also oversee the ... We have a strong growth trajectory and plan to accelerate this by
Industry veteran Korving previously took a group of agencies from start up through to acquisition by Publicis Health, to create the integrate service offerings Publicis Life Brands Resolute – now known as
Sarin will become AZ's new chief financial officer upon closing of the company’s acquisition of Alexion Pharmaceuticals. ... At AZ, she will succeed current chief financial officer Marc Dunoyer, who will step down from the role and retire from the
Keller’s appointment follows a number of recent acquisitions at Fishawack, including the healthcare marketing and scientific communications agency The Hive Health Group and the global market access consultancy PRMA Consulting.
More from appointments
Approximately 0 fully matching, plus 124 partially matching documents found.
Global healthcare communications company SCIRIS is delighted to announce the acquisition of UK-based Source Health Economics – an agency specialising in health economics and outcomes research (HEOR).
However, the acquisition of KaNDy by Bayer, and the recent unveiling by Astellas of positive topline results from two phase 3 clinical trials for their non-hormonal drug for moderate – severe
Metrics of interest usually include those more aligned to uptake (or acquisition), activation, and retention (see the AARRR framework to learn about some of these in more detail).
David was critical in the expansion of offerings for pharmaceutical and biotech companies, including leading the acquisition of Covance.
Brad Womble, Senior Director of Strategy, Marketing and Mergers &Acquisitions, at Jabil Healthcare dives into several thought-provoking topics, including how insights from “digital twins” can be used to improve patient
More from PMHub
Approximately 15 fully matching, plus 130 partially matching documents found.
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...